MENLO PARK, Calif.,
Feb. 1, 2016 /PRNewswire/
-- Veteran corporate dealmaker Marie-Louise Bots has joined
BioPharmX Corporation (NYSE MKT: BPMX) as senior vice president of
corporate development where she will help steer the company's
licensing and strategic partnerships worldwide. Bots joins
BioPharmX from Aon Risk Solutions where she most recently served as
its chief commercial officer.
She previously served as the head of the global skincare
business of Royal Philips Electronics NV, where she oversaw
partnership development, acquisitions and led a joint venture
project with a U.S. manufacturer of aesthetic skin resurfacing
devices. The collaboration led to the industry's first consumer
laser skincare device. She oversaw joint ventures with various
startup companies and was responsible for U.S. dermatology
licensing. She also created the Philips research and development
initiative that produced the intense pulse light (IPL) hair removal
device sold worldwide today.
While at Philips, she also served as general manager of oral
healthcare in EMEA, manufacturer of the Philips Sonicare toothbrush
systems, and collaborated in the first ever launch of an integrated
toothbrush with Procter & Gamble. Throughout her tenure she
managed numerous alliance and partnership programs garnering
significant growth for the company.
She was vice president of international business development at
Altadis USA, the world's leading
maker of cigars and a global leader in tobacco products. She
increased global sales by nearly 80 percent, oversaw contract
manufacturing and architected the conversion of multiple
geographical divisions to corporate subsidiaries.
In addition, as managing director of Reed/Elsevier Business
Information, she restructured the Dutch business operations
creating sustainable business models in publishing to energize its
marketing and sales whilst increasing profitability.
"I've developed a specialty in using licenses, partnerships and
acquisitions to accelerate sales, reduce costs, extend product
reach and improve profitability," said Bots. "I'm excited to
apply my experience at a company like BioPharmX, which embraces
innovation, to help it fulfill the unmet medical needs of patients
around the world."
Her success in accelerating the growth of several businesses and
transforming their operations led to her being recognized in 2009
as a "CEO of the Future" by Dutch business magazine "Management
Team."
"Our embrace of innovation – both in terms of R&D and
business development – has attracted top-quality executive talent,"
said Anja Krammer, president and
cofounder of BioPharmX. "We are excited to add a highly experienced
executive of Marie-Louise's caliber to our team."
Bots has a degree in Economics from Fontys University of Applied Sciences in Eindhoven,
Netherlands, and she has studied
at Erasmus University in Rotterdam and Babson
College in Boston.
She is a native Dutch speaker, and is fluent in English, German,
French, Spanish and Italian.
In connection with her appointment as senior vice president of
corporate development, the compensation committee of BioPharmX
Corporation's board of directors awarded Bots a non-qualified
stock option to purchase 200,000 shares of BioPharmX Corporation's
common stock at an exercise price of $1.55. Her stock option will vest at the rate of
25% of the shares on (i) the first anniversary of the commencement
of Bots' employment with the company, and then one forty-eighth
(1/48) of the shares monthly thereafter, subject to Bots' continued
service with BioPharmX. The stock option was granted as an
inducement material to Bots' employment in accordance with Section
711(a) of the NYSE MKT Company Guide.
About BioPharmX® Corporation
BioPharmX Corporation
(NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical
company, which seeks to provide products through proprietary
platform technologies for prescription, over-the-counter (OTC), and
supplement applications in the health and wellness markets,
including dermatology and women's health. To learn more about
BioPharmX, visit www.BioPharmX.com.
BioPharmX and Violet are registered trademarks of BioPharmX,
Inc. All other brand and product names are trademarks or registered
trademarks of their respective holders.
Logo - http://photos.prnewswire.com/prnh/20150711/235327LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-appoints-marie-louise-bots-as-senior-vp-of-corporate-development-300212503.html
SOURCE BioPharmX Corporation